NBP NovaBridge Biosciences - American Depositary Shares
$1.97
Price · Aug 19, 2026
52W Range
$1–$7
10% of range
Analyst Rating
BUY
9 analysts
Price Target
$8
+306% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NBP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.97
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $7
NBP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NBP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NBP
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NBP
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NBP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NBP
Peer Median
NBP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 3 33.3%
- Buy 5 55.6%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-19
Median
$8.00
← Below all targets
$1.97
Low
$7.00
High
$9.00
Median target
$8.00
+306.3%
Mean target
$8.00
+306.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.04%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.29 | $-0.05 | -0.24% |
| Sept. 30, 2025 | $-0.03 | $-0.05 | 0.02% |
| June 30, 2025 | $-0.07 | $-0.04 | -0.03% |
| March 31, 2025 | $-0.03 | $-0.07 | 0.04% |
| Dec. 31, 2024 | $-0.08 | $-0.06 | -0.02% |
| Sept. 30, 2024 | $-0.25 | $-0.23 | -0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NBP | — | — | — | — | — | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| CNXU | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 53 filers · $55.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 15 (+6 vs prior Q) | 11 (-6 vs prior Q) | 12 (-1 vs prior Q) | 11 (-5 vs prior Q) | -9.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $14,810,156 | 6,032,650 | 26.58% | Shares |
| HHLR ADVISORS, LTD. | $11,662,108 | 5,980,568 | 20.93% | Shares |
| AIHC Capital Management Ltd | $5,612,164 | 2,878,033 | 10.07% | Shares |
| Siren, L.L.C. | $3,909,241 | 2,004,739 | 7.02% | Shares |
| Candriam S.C.A. | $2,206,373 | 1,132,563 | 3.96% | Shares |
| S.A.C. Capital Advisors (Hong Kong) Ltd. | $2,121,963 | 561,366 | 3.81% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1,950,000 | 1,000,000 | 3.50% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,660,129 | 851,348 | 2.98% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,478,541 | 758,226 | 2.65% | Shares |
| CITADEL ADVISORS LLC | $1,214,520 | 622,831 | 2.18% | Shares |
| BlackRock, Inc. | $1,165,263 | 597,571 | 2.09% | Shares |
| E Fund Management Co., Ltd. | $1,148,589 | 589,020 | 2.06% | Shares |
| Exome Asset Management LLC | $1,125,072 | 576,960 | 2.02% | Shares |
| STATE STREET CORP | $702,733 | 360,376 | 1.26% | Shares |
| Woodline Partners LP | $682,500 | 350,000 | 1.22% | Shares |
| Fiera Capital Corp | $615,578 | 315,681 | 1.10% | Shares |
| UBS Group AG | $588,471 | 301,780 | 1.06% | Shares |
| BARCLAYS PLC | $544,087 | 279,019 | 0.98% | Shares |
| MARSHALL WACE, LLP | $391,639 | 200,840 | 0.70% | Shares |
| Taikang Asset Management (Hong Kong) Co Ltd | $333,315 | 170,931 | 0.60% | Shares |
| GOLDMAN SACHS GROUP INC | $314,576 | 161,321 | 0.56% | Shares |
| ALPS ADVISORS INC | $228,337 | 117,096 | 0.41% | Shares |
| EDBI Pte Ltd | $188,816 | 222,136 | 0.34% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $171,699 | 88,051 | 0.31% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $134,255 | 68,849 | 0.24% | Shares |
| Headlands Technologies LLC | $127,107 | 65,183 | 0.23% | Shares |
| Invesco Ltd. | $122,626 | 62,885 | 0.22% | Shares |
| CITADEL ADVISORS LLC | $67,665 | 34,700 | 0.12% | Call option |
| Caitong International Asset Management Co., Ltd | $59,048 | 30,281 | 0.11% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $56,230 | 28,836 | 0.10% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55,651 | 28,539 | 0.10% | Shares |
| Squarepoint Ops LLC | $51,613 | 26,468 | 0.09% | Shares |
| JANE STREET GROUP, LLC | $35,769 | 18,343 | 0.06% | Shares |
| China Universal Asset Management Co., Ltd. | $34,835 | 17,864 | 0.06% | Shares |
| TWO SIGMA SECURITIES, LLC | $30,500 | 15,641 | 0.05% | Shares |
| Aigen Investment Management, LP | $22,281 | 11,426 | 0.04% | Shares |
| Bronte Capital Management Pty Ltd. | $21,824 | 11,192 | 0.04% | Shares |
| Freestone Capital Holdings, LLC | $19,500 | 10,000 | 0.03% | Shares |
| JPMORGAN CHASE & CO | $17,133 | 8,653 | 0.03% | Shares |
| Mirae Asset Global Investments Co., Ltd. | $9,789 | 5,020 | 0.02% | Shares |
| Tower Research Capital LLC (TRC) | $8,436 | 4,326 | 0.02% | Shares |
| CITIGROUP INC | $5,148 | 2,640 | 0.01% | Shares |
| GF FUND MANAGEMENT CO. LTD. | $4,635 | 2,377 | 0.01% | Shares |
| PNC Financial Services Group, Inc. | $3,900 | 2,000 | 0.01% | Shares |
| SIMPLEX TRADING, LLC | $3,835 | 1,967 | 0.01% | Shares |
| MORGAN STANLEY | $2,874 | 1,474 | 0.01% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $1,811 | 1,104 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $279 | 143 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $146 | 75 | 0.00% | Shares |
| SG Americas Securities, LLC | $74 | 38,198 | 0.00% | Shares |
| RHUMBLINE ADVISERS | $64 | 33 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $58 | 30 | 0.00% | Shares |
| Eurizon Capital SGR S.p.A. | $2 | 1 | 0.00% | Shares |
Company insiders 6 insiders · 5 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Srishti Gupta | Chief Executive Officer | July 6, 2026 A | — | 0 | 0 | $0 |
| Mark Arnold Hagler | President and Chief Commercial Officer | April 24, 2026 P | 230,000 | 1 | 0 | $577,300 |
| Cong Claire Xu | SVP, Clinical Development | July 4, 2026 M | 298,101 | 0 | 2 | $-17,758 |
| Sean Wuxiong Cao | Chief Bus. Development Officer | June 22, 2026 A | 35,073 | 0 | 1 | $-42,584 |
| Phillip Andrew Dennis | Chief Medical Officer | June 17, 2026 M | 157,941 | 0 | 1 | $-5,606 |
| Wei Fu | Director | June 29, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| CBC Investment I-Mab Limited, IBC Investment Seven Limited, CBC SPVII LIMITED, C-Bridge II Investment Ten Limited, Nova Aqua Limited, C-Bridge Healthcare Fund II, L.P., C-Bridge Healthcare Fund GP II, L.P., C-Bridge Capital GP, Ltd., I-Bridge Healthcare Fund, L.P., I-Bridge Healthcare GP, L.P., I-Bridge Capital GP, Ltd., Wei Fu ×3 filings | Feb. 3, 2026 | 0.00% | Amendment | — | SEC |
| Everest Medicines Limited | Aug. 5, 2025 | 16.10% | Initial filing | Passive investment | SEC |
| T INVESTMENT LIMITED | Dec. 1, 2023 | — | Initial filing | Passive investment | SEC |
| HHLR Advisors, Ltd., Hillhouse Investment Management, Ltd. ×2 filings | June 30, 2023 | — | Initial filing | — | SEC |
| Hillhouse Capital Advisors, Ltd., Hillhouse Capital Management, Ltd. ×4 filings | June 24, 2021 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.